Lyme is Moderna’s first attempt at creating a vaccine for a bacterial infection.
There are around 120,000 Lyme disease cases reported in the U.S. and Europe each year and Moderna said the proposed vaccines target key species of the tick-borne bacteria responsible for most infections in the regions.
Vaccinating against bacterial infections like Lyme is generally more complicated than protecting against viral infections like Covid, and the effort marks the first time Moderna has applied its mRNA technology to bacterial threats. Moderna also announced plans to develop mRNA vaccines targeting norovirus, which is highly contagious and the leading cause of diarrheal disease globally.for years to commercialize its mRNA technology before achieving stellar success with its Covid-19 vaccine during the pandemic. With demand for those shots waning, it is under intense pressure to diversify its offerings.
conditions and infectious diseases like HIV, herpes simplex virus and cytomegalovirus in the pipeline.Moderna said it expects six “major vaccine” launches in the “next few years.” On Tuesday, Moderna said it plans to seek regulatory approval for its latest RSV vaccine this quarter. The company pushed back its timeline for its flu shot, however, citing the need to gather more data.$15 billion. That’s how much Moderna estimates the annual global market for Covid booster shots is worth.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Moderna is developing a vaccine candidate against Lyme disease that would be its first bacterial vaccineModerna Inc. outlined its clinical goals for its mRNA platform on Tuesday to mark its 4th Vaccine Day, including a new development candidate against Lyme...
Read more »
COVID-19: Mitigating the spread and the role vaccines playServices are still being offered to mitigate the spread of COVID-19 in the community.
Read more »
Abortion Pill Ruling Could Threaten Vaccines, Contraception, Advocates SayAbortion rights advocates and former FDA officials warned that a federal court decision on medication abortion puts all other FDA-approved drugs at risk.
Read more »
White House launching $5B program for next-gen COVID vaccinesThe White House is launching a $5 billion effort to develop next-generation COVID-19 vaccines and rekindle some of the momentum from Operation Warp Speed, the Washington Post reports.
Read more »
U.S. spending $5 billion to speed up development of new COVID vaccinesThe U.S. government is spending over $5 billion on an effort to speed up the development of new COVID-19 vaccines and treatments, a Department of Health and Human Services (HHS) spokesperson and a Biden administration official said on Monday.
Read more »
Biden team eyeing $5B to develop the next generation of COVID vaccines, treatmentsThe Biden administration plans to invest $5 billion in a program to develop the next generation of COVID-19 vaccines and treatments, including nasal sprays that could thwart transmission and shots that protect against a range of coronaviruses.
Read more »